The global Idiopathic Pulmonary Fibrosis Treatment Market size was valued at USD 2.00 billion in 2018 and is estimated to expand at a CAGR of 12.7% over the forecast period. Increasing prevalence of idiopathic pulmonary fibrosis (IPF) and increasing geriatric population are the key drivers of the market. Rising number of cigarette smoking people, leading to a high prevalence of IPF, is also projected to fuel the growth. Aging is considered as the greatest risk factor for development. Hence, the fact that the global base of geriatric population is anticipated to grow over the forecast period and is expected to serve this market as a high impact rendering driver. According to the World Population Aging Report 2015 by the United Nations.
The global Idiopathic Pulmonary Fibrosis Treatment Market size was valued at USD 2.00 billion in 2018 and is estimated to expand at a CAGR of 12.7% over the forecast period. Increasing prevalence of idiopathic pulmonary fibrosis (IPF) and increasing geriatric population are the key drivers of the market. Rising number of cigarette smoking people, leading to a high prevalence of IPF, is also projected to fuel the growth. Aging is considered as the greatest risk factor for development. Hence, the fact that the global base of geriatric population is anticipated to grow over the forecast period and is expected to serve this market as a high impact rendering driver. According to the World Population Aging Report 2015 by the United Nations.
ReplyDelete